• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Repeated medial branch blocks do not improve pain outcomes for thermal radiofrequency ablation

byPaary BalakumarandAlex Chan
June 21, 2025
in Cardiology, Neurology, Pediatrics Classics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. For patients with facet-mediated spine pain that achieve ≥80% pain relief after a medial branch block, a second diagnostic block does not improve post-radiofrequency ablation pain outcomes but may delay definitive treatment.

Evidence Rating Level: 2 (Good) 

This retrospective study examined whether receiving one versus two medial branch blocks (MBBs) prior to thermal radiofrequency ablation (tRFA) influenced pain outcomes in patients with facet-mediated spine pain. Existing guidelines often recommend dual MBBs before tRFA, though their necessity remains controversial. At a single academic center, 645 tRFA procedures performed between 2017 and 2021 were screened, yielding 312 cases with adequate follow-up data: 161 underwent one MBB and 151 received two. All patients had ≥80% pain relief after MBB, the center’s threshold for a positive diagnostic block. Pain outcomes at 3 months post-tRFA were assessed and compared using t-tests and χ² analyses. The average reported pain relief was 69.5%, with 85.3% of patients reporting ≥50% relief and 58.3% reporting ≥80% relief—no significant differences emerged between the one- and two-block groups. However, the time from the first MBB to tRFA was significantly longer in the two-block group (95.3 vs. 44.2 days, p<0.001). These findings align with prior research suggesting minimal added value of a second diagnostic block in predicting tRFA success and support recent guideline revisions discouraging routine use of dual MBBs. Limitations include the retrospective design, exclusion of many cases due to incomplete data, and reliance on self-reported pain outcomes.

Click to read the study in RAPM

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

RELATED REPORTS

Apixaban (eliquis) outperforms Rivaroxaban (xarelto) in venous thromboembolism bleeding risk

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

Increased local anesthesia volume may not improve pain control in popliteal plexus block following total knee arthroplasty

Tags: anesthesiacardiologynerve blockpain medicine
Previous Post

Early screening for emotional and cognitive issues may improve psychiatric outcomes for stroke patients

Next Post

Reductions in pain catastrophizing are associated with improvements in emotional functioning

RelatedReports

Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization
Cardiology

Apixaban (eliquis) outperforms Rivaroxaban (xarelto) in venous thromboembolism bleeding risk

April 9, 2026
2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
Endocrinology

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

March 30, 2026
Social networks play key roles in parental vaccination decisions
Imaging and Intervention

Increased local anesthesia volume may not improve pain control in popliteal plexus block following total knee arthroplasty

March 23, 2026
Risk of autism in offspring linked to maternal pregestational diabetes and severe obesity
Weekly Rewinds

2 Minute Medicine Rewind March 23, 2026

March 23, 2026
Next Post
Parental nonmedical prescription opioid use linked to adolescent use

Reductions in pain catastrophizing are associated with improvements in emotional functioning

2 Minute Medicine Rewind June 23, 2025

Patient Basics: Lung Cancer Overview

Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • NVIDIA GTC 2026 unveils Isaac GR00T foundation model for surgical robotics
  • Mezagitimab appears safe and potentially effective for persistent immune thrombocytopenia
  • Intensive multifaceted management may improve blood pressure control among low-income patients
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

The Classics in Medicine Paperback Released!

Over the past 30 years, the transition from print to digital media has contributed to an exponential increase in medical literature. In response, 2 Minute Medicine presents 160+ authoritative, physician-written summaries of the most cited landmark trials in medicine.

amazon-logo_blackGet-it-on-iBooks-badge

Click anywhere to close this announcement

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.